Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

Journal of the American Academy of Dermatology
Mette DeleuranMarius Ardeleanu

Abstract

Significant unmet need exists for long-term treatment of moderate to severe atopic dermatitis (AD). To assess the long-term safety and efficacy of dupilumab in patients with AD. This ongoing, multicenter, open-label extension study (NCT01949311) evaluated long-term dupilumab treatment in adults who had previously participated in phase 1 through 3 clinical trials of dupilumab for AD. This analysis examined patients given 300 mg dupilumab weekly for up to 76 weeks at data cutoff (April 2016). Safety was the primary outcome; efficacy was also evaluated. Of 1491 enrolled patients (1042.9 patient-years), 92.9% were receiving treatment at cutoff. The safety profile was consistent with previously reported trials (420.4 adverse events/100 patient-years and 8.5 serious adverse events/100 patient-years), with no new safety signals; common adverse events included nasopharyngitis, conjunctivitis, and injection-site reactions. Sustained improvement was seen up to 76 weeks in all efficacy outcomes, including measures of skin inflammation, pruritus, and quality of life. Lack of control arm, limited number of patients with 76 weeks or longer of treatment (median follow-up, 24 weeks), and patients not receiving the approved dose regimen of 300 ...Continue Reading

Citations

Nov 26, 2019·JAMA Pediatrics·Ann Chen Wu
Apr 25, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·S FerrucciS Tavecchio
Sep 8, 2020·Immunotherapy·Kayla FourzaliGil Yosipovitch
Jun 4, 2020·Allergy & Rhinology·Marija RowaneRobert Hostoffer
Jul 16, 2020·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Margitta WormAikaterina Alexiou
Apr 24, 2020·American Journal of Clinical Dermatology·Wenelia BaghoomianEric L Simpson
Jun 11, 2020·Drugs·Megan NewsomLindsay C Strowd
Jul 2, 2020·American Journal of Clinical Dermatology·Radomir ReszkeJacek C Szepietowski
Sep 27, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·S M FerrucciA V Marzano
Oct 29, 2020·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Margitta WormAikaterina Alexiou
Nov 12, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·Johannes WohlrabAndreas Wollenberg
Oct 1, 2020·The British Journal of Dermatology·E NettisS M Ferrucci
Dec 5, 2020·Expert Review of Clinical Immunology·Carla Tubau, Lluís Puig
Jan 13, 2021·Immunotherapy·Carla Tubau, Lluís Puig
Dec 29, 2020·JAAD Case Reports·Marissa AyasseJonathan I Silverberg
Jan 23, 2021·American Journal of Clinical Dermatology·Ashish BansalMarius Ardeleanu
Feb 22, 2021·International Forum of Allergy & Rhinology·Claire HopkinsRajesh Rout
Mar 23, 2021·Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'oto-rhino-laryngologie Et De Chirurgie Cervico-faciale·Andrew ThambooM Desrosiers
Aug 3, 2020·Lancet·Sinéad M LanganStephan Weidinger
Apr 8, 2021·Ocular Immunology and Inflammation·Sneha PadidamBrian Do
Apr 24, 2021·Journal of Autoimmunity·Tina De Bruyn CarlierInge Kortekaas Krohn
May 13, 2021·Nature Communications·Eva CondeLaurent L Reber
Jul 7, 2021·Immunology and Allergy Clinics of North America·Sara BilimoriaPeter Lio
Aug 3, 2020·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jonathan I SilverbergJessica J Jalbert
Jul 27, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·E NettisUNKNOWN STUDY GROUP
Aug 22, 2021·Nature Reviews. Drug Discovery·Thomas Bieber
Sep 5, 2021·International Journal of Dermatology·Filomena RussoPietro Rubegni

Dec 4, 2020·Annales de dermatologie et de vénéréologie·E Sbidian
Dec 18, 2020·Dermatitis : Contact, Atopic, Occupational, Drug·Filomena RussoMaria Laura Flori
Oct 10, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·L VuillemeyF Aubin
Mar 19, 2021·Dermatology : International Journal for Clinical and Investigative Dermatology·Shuying ZhouBinghua Zhu
Nov 13, 2021·Expert Review of Clinical Immunology·David Watchorn, Fernando Holguin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Related Papers

Journal of the American Academy of Dermatology
Melinda J GooderhamKim Papp
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia
Maria A RodriguesTiago Torres
The New England Journal of Medicine
Eric L SimpsonSOLO 1 and SOLO 2 Investigators
© 2021 Meta ULC. All rights reserved